Boston team wins grant to study drug-resistant TB
A team of Boston investigators has received a federal grant to understand drug-resistant tuberculosis.
Researchers from Harvard, Brigham and Women’s Hospital, and Partners in Health will use a five-year, $14 million grant from the National Institutes of Health to study how multidrug-resistant and extensively drug-resistant strains of TB are developed and transmitted. The basic and drug-resistant forms of tuberculosis combine to kill 2 million people a year worldwide.
Dr. Megan Murray of the Harvard School of Public Health and the Brigham is the principal investigator. She will work with project co-leaders Mercedes Becerra, Partners in Health founder Dr. Paul Farmer, and Dr. Lucila Ohno-Machado, all of Harvard Medical School and the Brigham.
This blogger might want to review your comment before posting it.
Contributors
blogger
Elizabeth Cooney covers health for the Worcester Telegram & Gazette. She
previously reported on business and was an editor at the paper. Earlier in
her career, she edited medical books and journals at Little, Brown, and
worked for Boston magazine.Boston Globe Health and Science staff:
- Karen Weintraub, Deputy Health and Science Editor
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger
- Joshua U. Klein, M.D., Short White Coat blogger
